ALK p.Arg1275Gln
c.3824G>A · rs113994087 · VCV18083
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9906 | likely pathogenic ✓ concordant with ClinVar · top 9% in ALK |
|---|---|---|
| REVEL | 0.885 | moderately pathogenic-leaning |
| SaProt | LLR -14.26 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2.4, phastCons 1 |
| Regional constraint | o/e 0.59 | unconstrained · MANE · 16 kb · p 1.6e-06 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Cancer therapy — CIViC
| Disease | Therapies | Level | Significance |
|---|---|---|---|
| Neuroblastoma | Crizotinib | C | Sensitivity/Response |
| Neuroblastoma | Crizotinib | C | Sensitivity/Response |
| Neuroblastoma | Lorlatinib | D | Sensitivity/Response |
| Neuroblastoma | Crizotinib | D | Sensitivity/Response |
| Neuroblastoma | Crizotinib | B | Sensitivity/Response |
| Neuroblastoma | ALK Inhibitor TAE684 | D | Sensitivity/Response |
| Neuroblastoma | ALK Inhibitor TAE684 | D | Resistance |
| Neuroblastoma | B | Predisposition |
Variant & gene context
- Gene
- ALK
- Protein
- p.Arg1275Gln
- Coding
- c.3824G>A
- MANE Select
- NM_004304
- dbSNP
- rs113994087
- Type
- single nucleotide variant
- Location
- chr2:29209798 (GRCh38)
- Gene constraint
- LOEUF 0.562 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 68.26 · 79 PDB
- Residue 1275
- an α-helix; a UniProt-annotated variant site (observed in neuroblastoma); a UniProt-annotated variant site (in nblst3; constitutively activated; retained in the endoplasmic reticulum and golgi compartments); the protein kinase domain
Similar variants
- ALK p.Arg1275Ter Uncertain significance ★★ same residue
- ALK p.Arg1275= Likely benign ★ same residue
- ALK c.1154+5G>A Uncertain significance ★★ same condition
- ALK c.1155-3C>T Uncertain significance ★★ same condition
- ALK c.1282+3A>G Uncertain significance ★★ same condition
- ALK c.1414+1G>A Uncertain significance ★★ same condition
- ALK c.1414+3G>A Uncertain significance ★★ same condition
- ALK c.1415-3T>C Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alk-p-arg1275gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown